The enzyme SKG1 may be a useful target in treating asthma and boosting the effects of certain cancer therapies, according to researchers from Johns Hopkins Kimmel Cancer Center.
Grastek, a sublingual allergen extract manufactured by Merck & Co Inc, has received FDA approval as an immunotherapy for the treatment of Timothy grass pollen-induced allergic rhinitis.
The NIH grant will help the Icahn School of Medicine at Mount Sinai research pandemic preparedness and advance the understanding of influenza biology.
The protein DDX21 has been found to block the cellular replication process that takes place when an influenza virus infects a human cell, according to Scientists at The University of Texas at Austin.
Scientists at Georgia Tech, Emory University, and the CDC are experimenting with a new delivery method for the influenza vaccination: a “Flu patch.” The small Band-Aid sized adhesive patch could potentially allow self-administration of the vaccine while also eliminating most of the pain of the traditional flu shot.
In the last 30 years, COPD has become more prevalent in American women, who now make up more than half of patients currently diagnosed—an estimated 7 million women, in all.
An innovative, low-cost bubble CPAP device designed by undergraduates at Rice University is saving the lives of Malawi’s preterm newborns suffering from severe respiratory complications.
Initiatives across the country are expanding access to quality spirometry, a key component in the proper diagnosis and treatment of respiratory conditions like COPD and asthma.
The FDA has approved Pradaxa (dabigatran etexilate mesylate) for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) in certain patients, according to Boehringer Ingelheim Pharmaceuticals.
Researchers from Brigham and Women’s Hospital and Harvard Medical School estimate the number of childhood TB cases is double previous estimates: about 1 million annually with 32,000 suffering from multidrug-resistant TB.